These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 17010055)

  • 1. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Br J Cancer; 2005 Mar; 92(5):857-66. PubMed ID: 15756256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
    Henningson M; Bågeman E; Sandberg T; Borg A; Olsson H; Jernström H
    Fam Cancer; 2007; 6(4):445-52. PubMed ID: 17484040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
    Jernström H; Sellberg G; Borg A; Olsson H
    Eur J Cancer Prev; 2006 Jun; 15(3):233-41. PubMed ID: 16679866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
    Henningson M; Hietala M; Törngren T; Olsson H; Jernström H
    Fam Cancer; 2011 Jun; 10(2):173-85. PubMed ID: 21113804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
    Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA
    Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
    Henningson M; Johansson U; Borg A; Olsson H; Jernström H
    Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.
    Jernström H; Borg K; Olsson H
    Mol Genet Metab; 2005; 86(1-2):320-7. PubMed ID: 16084122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.
    Bågeman E; Ingvar C; Rose C; Jernström H
    Br J Cancer; 2007 Mar; 96(5):712-7. PubMed ID: 17311016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.
    Figer A; Karasik YP; Baruch RG; Chetrit A; Papa MZ; Sade RB; Rizel S; Friedman E
    Isr Med Assoc J; 2002 Oct; 4(10):759-62. PubMed ID: 12389335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
    Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
    Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
    McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
    Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
    Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
    Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.
    Kim J; Johnson L; Skrzynia C; Buchanan A; Gracia C; Mersereau JE
    Cancer Causes Control; 2015 Aug; 26(8):1087-92. PubMed ID: 26006218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
    Hudelist G; Wagner T; Rosner M; Fink-Retter A; Gschwantler-Kaulich D; Czerwenka K; Kroiss R; Tea M; Pischinger K; Köstler WJ; Attems J; Mueller R; Blaukopf C; Kubista E; Hengstschläger M; Singer CF
    Endocr Relat Cancer; 2007 Dec; 14(4):1053-62. PubMed ID: 18045956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.
    Antoniou AC; Rookus M; Andrieu N; Brohet R; Chang-Claude J; Peock S; Cook M; Evans DG; Eeles R; ; Nogues C; Faivre L; Gesta P; ; van Leeuwen FE; Ausems MG; Osorio A; ; Caldes T; Simard J; Lubinski J; Gerdes AM; Olah E; Fürhauser C; Olsson H; Arver B; Radice P; Easton DF; Goldgar DE
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):601-10. PubMed ID: 19190154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive factors in hereditary breast cancer.
    Jernström HC; Johannsson OT; Loman N; Borg A; Olsson H
    Breast Cancer Res Treat; 1999 Dec; 58(3):295-301. PubMed ID: 10718491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.